Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: Dose Adjustment For Normal Eating (DAFNE) randomised controlled trial
Patients were randomly assigned to receive BYDUREON BCISE 2 mg given subcutaneously once every 7 days (weekly) (n=181), sitagliptin 100 mg/day (n=122) or placebo (n=61), in addition to their existing metformin therapy
You can start seeing results from fat dissolving injections after 2 to 4 weeks, as the body gradually breaks down and eliminates the fat cells, with improvements continuing over time
For detailed timelines of what to expect month by month, see our semaglutide weight loss results guide for Wegovy and our tirzepatide results guide for Zepbound
In the case of severe bleeding, distribution factors may also be different
Medical History: Discuss your medical history with your healthcare provider